Aim: Radiochemotherapy for small-cell lung cancer may not be sufficiently tolerated by all
patients. To contribute to better personalization of the radiochemotherapy programs, this …

Introduction Most patients with limited disease small cell lung cancer (LD-SCLC) receive
definitive radiochemotherapy. Some patients cannot withstand combined modality …

Background: Small-cell lung cancer is highly chemo-and radiosensitive tumor. We evaluated
two different radiotherapy doses applied sequentially with chemotherapy in relation to time …

Aims and Background Small cell lung cancer is characterized by an aggressive clinical
course and a high sensitivity to both chemotherapy and radiotherapy. We present the …

Purpose: To evaluate the rate of tumor recurrence within the irradiated volume after initial
low-dose irradiation of limited-stage small-cell lung cancer (SCLC), to assess the tolerance …

Small cell lung cancer (SCLC) is an aggressive disease, in which more than 80% of patients
present distant metastases at the time of first diagnosis. Chemotherapy is considered as the …

Aims and Background Small cell lung cancer is an aggressive histologic subtype of lung
cancer in which the role of chemotherapy and radiotherapy has been well established in …

PURPOSE: To review the treatment outcomes of limited-stage small-cell lung cancer (LS-
SCLC) patients and to compare the outcomes among three groups in which the total …

Background To investigate the biological radiation dose-response for patients of limited-
stage small-cell lung cancer (LS-SCLC) treated with high radiation dose. Methods Two …

Objective Thoracic radiotherapy (TRT) is a critical component of the treatment of limited-
stage small cell lung cancer (LS-SCLC). However, the optimal radiation dose/fractionation …